STSabah Tuzun

Sabah Tuzun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sabah Tuzun has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Contraceptive Method Choice and Partner Decision-Making in Primary Care: A Cross-Sectional Study

    by Beyza Arpacı Saylar, Fatma Karaşabanoğlu, Sabah Tuzun, Reşat Dabak

    Background:Understanding contraceptive method preferences is essential for improving family planning services and reducing unintended pregnancies. In Turkey, community-based evidence on contraceptive preferences and associated factors at the primary care level remains limited.Objective:To examine contraceptive method preferences and factors associated with method choice among sexually active women aged 15–49 years in Turkey.Methods:This cross-sectional study was conducted at a family health center in the Bağcılar district of Istanbul between January and March 2020. A structured 7-item questionnaire was administered to 223 sexually active women aged 15–49 years. Data on sociodemographic characteristics, parity, age at marriage, smoking status, current contraceptive method, and decision-maker regarding method choice were collected. Associations between contraceptive method preference and categorical variables were explored using chi-square or Fisher’s exact tests, as appropriate.Results:The most frequently reported contraceptive methods were male condoms (33.2%) and intrauterine devices (IUDs) (25.1%). Contraceptive method preference differed significantly according to decision-maker, age group, educational level, age at marriage, and parity (all p

  • Open Access

    Assessment of Cardiovascular Risk and Examination of Blood Klotho Levels in Patients with Ankylosing Spondylitis

    by Burcu Dogan, Aysel Tocoglu, Sabah Tuzun, Ulku Akcay, Ayfer Altas, Emel Gonullu, Ali Tamer

    Background/Objectives: Ankylosing Spondylitis (AS) is associated with increased cardiovascular disease risk due to chronic systemic inflammation. The Atherogenic Index of Plasma (AIP) and Systematic Coronary Risk Evaluation (SCORE) are valuable tools for cardiovascular risk assessment, while Klotho, an anti-aging protein with cardioprotective properties, may serve as a potential biomarker for cardiovascular health. Recent studies have shown that soluble α-Klotho contributes to vascular protection by increasing endothelial cell proliferation, reducing apoptosis, and enhancing angiogenic capacity, thereby helping to maintain microvascular integrity. We aimed to assess cardiovascular event risk in AS patients using AIP and SCORE and investigate the relationship between serum Klotho levels and these factors. Methods: A case–control study was conducted between August and September 2019. The study included 24 AS patients and 24 healthy controls aged 18 and above, with 13 females and 11 males. Results: No significant difference was found in serum Klotho levels between the AS and control groups in terms of SCORE and AI classifications. In the high-risk SCORE classification group, AI was found to be elevated at 0.42. In the AS group, Klotho levels were observed as 0.73 in the low-risk group, 0.60 in the moderate-risk group, and 0.61 in the high-risk group (p = 0.974). When evaluating HDL levels, Klotho was determined to be 7.29 ± 6.81 for HDL < 35 and 0.60 [0.33] for HDL ≥ 35 (p = 0.036). Conclusions: An AI exceeding 0.40 in the high-risk SCORE group and in patients with active disease according to the BASDAI score indicated an increased cardiovascular event risk in the AS group. Further studies are warranted regarding serum Klotho levels, HDL, and LDL subclasses in AS patients.


  • Serum γ-Klotho and Fibroblast Growth Factor-2 Levels in Patients with Pressure Ulcers

    by Sabah Tüzün, Burcu Hacıoğlu, Can Oner, Cemal Unal, Macit Koldas, Mustafa Reşat Dabak

    Introduction: This study aimed to evaluate the serum levels of γ-Klotho and fibroblast growth factor 2 (FGF2) in patients with pressure ulcers.Material and methods: Patients aged ≥18 years receiving care from Home Health Services were included. The case group consisted of individuals with stage 2–4 pressure ulcers, while the control group comprised patients without ulcers, matched for age or gender. Sociodemographic characteristics, medical device usage, and nutritional status were assessed for all participants. In the case group, additional data regarding ulcer site, stage, number, and dimensions were collected. Serum levels of γ-Klotho and FGF2 were measured using the ELISA method.Results: A total of 80 participants were enrolled (40 (50.0%) in each group). FGF2 level was 220.8 [26.8] pg/mL in the case group and 219.1 [29.1] pg/mL in the control group (p=0.577). Similarly, γ-Klotho was 1448.4 [158.6] pg/mL in the case group and 1421.3 [232.8] pg/mL in the control group (p=0.453). Conversely, a significant correlation was observed between γ-Klotho and FGF2 levels in the case group (p = 0.048), whereas no such association was found in the control group (p = 0.164). Additionally, FGF2 levels were positively associated with the number, width, and length of the wounds (p=0.003, p=0.007, and p=0.012, respectively), while a negative correlation was observed between γ-Klotho levels and wound duration (p=0.026).Conclusions: Although serum levels did not differ between groups, the exclusive correlation between γ-Klotho and FGF2 in the pressure ulcer group may indicate a role in chronic wound processes, warranting further investigation.

  • Effect of structured individual and combined education on blood glucose regulation in type 2 diabetes mellitus

    by Zarif Cagla Arslan, Sabah Tuzun, Can Öner, Nazli Haciağaoğlu, Hüseyin Çetin, Engin Ersin Şimşek

    Although various approaches have been used in diabetes self-management education (DSME) programs, the effect of DSME programs on glycemic control is controversial. This study aimed to compare the effects of structured individual education and combined education on glycemic regulation in type 2 diabetes mellitus (T2DM). This study included T2DM patients who applied to the Ust Kaynarca Diabetes Center between 1 January 2018 and 11 March 2020. All data were retrospectively evaluated from hospital information systems. Patients who received only individual education were defined as the individual education group (IEG), and patients who received both individual and group education were defined as the combined education group (CEG). A total of 496 T2DM patients, with 248 (50.0%) in the IEG and 248 (50.0%) in the CEG, were included in the study. The change in HbA1c (ΔHbA1c) value for the IEG was 1.0% (2.5%), while the ΔHbA1c value for the CEG was 1.9% (2.8%) (P < 0.001). When factors affecting the glycemic control were evaluated, it was determined that the type of education [odds ratio (OR) = 2.295, P < 0.001], gender (OR = 1.799, P = 0.007), presence of hyperlipidemia (OR = 0.559, P = 0.032) and presence of medications added to treatment (OR = 1.558, P = 0.041) were effective on glycemic control. Combined education, in which individual and group education are conducted together, is more effective than individual education in glucose regulation.

  • Open Access

    Serum α-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus

    by Can Oner, Burcu Dogan, Sabah Tuzun, Asiye Ekinci, Gunes Feyizoglu, Banu Isbilen Basok

    Diabetic retinopathy is a commonly observed cause of blindness and is a common problem in individuals with diabetes. Recent investigations have showed the capability of serum α-Klotho and FGF 23 in mitigating the effects of diabetic retinopathy. This study aimed to discover the correlation between FGF 23, α-Klotho, and diabetic retinopathy in type 1 diabetics. This case–control study included 63 diabetic patients and 66 healthy controls. Following an overnight duration of fasting, morning blood samples were taken from both the patient and the control groups. The serum concentrations of α-Klotho and FGF 23 were quantified. An experienced ophthalmologist inspected the retinopathy. All participants in this study have moderate non-proliferative retinopathy. A p value under 0.05 was considered statistically significant. The mean α-Klotho level for retinopathic diabetic patients was 501.7 ± 172.2 pg/mL and 579.6 ± 312.1 pg/mL for non-retinopathic diabetic patients. In comparison, α-Klotho level of the control group was 523.2 ± 265.4 pg/mL (p = 0.531). The mean of FGF 23 level did not demonstrate a significant difference (p = 0.259). The mean FGF 23 level were 75.7 ± 14.0 pg/mL, 74.0 ± 14.8 pg/mL and 79.3 ± 14.4 pg/mL in groups, respectively. In conclusion, there was no significant difference in FGF 23 and α-Klotho levels between type 1 diabetics with and without retinopathy when compared to the control group.


  • Open Access

    Ankilozan Spondilit Hastalarında Hastalık Aktivitesi ile Sistemik İnflamasyon İndeksi ve Trombosit Albumin Oranı Arasındaki İlişki The relationship Between Disease Activity and Systemic Inflammation Index and Platelet Albumin Ratio in Patients with Ankylosing Spondylitis

    by Aysel Toçoğlu, Emine Ülkü Akçay, Ayfer Erdoğan Altaş, Sabah Tuzun, Burcu Doğan, Emel Gönüllü

    Amaç: Sistemik İnflamasyon indeksi (SII) ve trombosit albümin oranı (PAR) inflamasyonu değerlendirmek için öne sürülen yeni biyobelirteçlerdir. Çalışmamızda Ankilozan Spondilit (AS) hastalarında hastalık aktivitesi ile SII ve PAR arasındaki ilişkiyi incelemeyi amaçladık. Yöntem ve Gereçler: AS’li 79 hasta ile 79 sağlıklı kontrol retrospektif olarak değerlendirildi. Katılımcıların demografik, klinik ve laboratuvar verileri poliklinik verileri incelenerek hastane bilgi sistemi üzerinden kayıt edildi. AS grubunda hastalık aktivite durumu Bath Ankilozan Spondilit Hastalık Aktivite İndeksi (BASDAI) skoru hesaplanarak tayin edildi. BASDAI skoru ≥4 olanlar aktif hasta olarak kabul edildi. Aktif hastalığı olan AS hastaları ile remisyonda olan hastalar SII ve PAR açısından karşılaştırıldı. Bulgular: AS grubunun yaş ortalaması 42,53±6,60, sağlıklı grubun 41,37±10,86 yıldı (p=0,460). AS grubunda 49 (%62,0), sağlıklı grupta 35 (44,3) katılımcı erkekti (p=0,026). AS grubunda sağlıklı gruba göre SII, PAR ve C-reaktif protein albümin oranı (CAR) değerlerinin istatistiksel olarak anlamlı oranda daha yüksek olduğu tespit edildi (sırasıyla p 0.05). Sonuç: AS hastalarında sağlıklı kontroller ile karşılaştırıldığında SII ve PAR değerlerinin artmış olduğu tespit edilirken, beklenenin aksine hastalık aktivitesi ile SII ve PAR değerleri arasında herhangi bir ilişki tespit edilemedi.

  • Open Access

    Change of pulmonary function tests in hospitalized COVID-19 patients at third and sixth month follow-up

    by Meltem Karakulak Kafkas, Sabah Tüzün, Nazlı Hacıağaoğlu, Hüseyin Çetin, Sevda Şener Cömert, Engin Ersin Şimşek

    The effect of COVID-19 infection on pulmonary function is unknown. This study aimed to evaluate pulmonary function tests (PFTs) of patients hospitalized with the diagnosis of COVID-19 pneumonia at 3 and 6 months post-discharge. Patients aged 18 years and over who had positive COVID-19 PCR test results and were hospitalized in the pandemic service between 1 May 2020 and 31 October 2020, were included in the study. All patients were evaluated with PFTs FVC, FEV1, FEV1/FVC, and FEF25–75 at 3 and 6 months after discharge. The mean age of 34 patients included in the study was 47.7 ± 12.7 years. The FVC, FEV1, FEV1/FVC, and FEF25–75 measurements at 3 and 6 months post-discharge showed no significant difference (P = 0.765, P = 0.907, P = 0.707, and P = 0.674, respectively). There was no significant difference in any PFT measurements at the third month follow-up, regardless of the pharmacological treatment protocols applied during hospitalization (P > 0.05). However, FEV1/FVC and FEF25–75 levels were 83.1 [3.4]% and 91.0 [10.0]%, respectively, in those who received systemic steroid treatment, and 78.3 ± 8.5% and 72.5 ± 25.7% in those who did not (P = 0.019 and P = 0.048, respectively). In addition, FVC and FEV1 levels increased significantly from the third to the sixth month follow-up in patients who received systemic steroid therapy (P = 0.035 and P = 0.018, respectively). Although there is no significant difference in PFT measurements from 3 to 6 months in COVID-19 patients, systemic steroid therapy may have a beneficial effect on respiratory function in COVID-19 patients.


  • Open Access

    Diyabet Merkezden Takipli Tip 2 Diabetes Mellitus Hastalarında Hipoglisemi Sıklığı ve Hipoglisemi Korkusu

    by Sema Gizem Çalişkan, Nazlı HACIAĞAOĞLU, Sabah Tuzun, Can Öner, Engin Ersin Şi̇mşek, Huseyin Ceti̇n

    Giriş: Bu çalışma aile hekimliği yönelimli diyabet merkezi (AHYDM) ile hastane yönelimli diyabet merkezi (HYDM)’den takipli tip 2 diabetes mellitus (DM) hastalarında hipoglisemi sıklığı ve ilişkili faktörlerin karşılaştırılmasını amaçlamaktadır. Yöntem: Bu çalışmaya 1 Aralık 2017– 31 Aralık 2019 tarihleri arasında aynı hastaneye bağlı olan iki diyabet merkezine başvuran Tip 2DM hastaları dahil edilmiştir. Çalışmada hastane içerisinde yer alan ve İç Hastalıkları Kliniği tarafından yürütülen DM merkezi HYDM olarak kabul edilirken, hastane kampüsü dışında bulunan, Aile Hekimliği Kliniği tarafından yürütülen DM merkezi ise AHYDM olarak kabul edilmiştir. Her iki merkezdeki açlık plazma glukozu düzeyi en az iki defa 70 mg/dL’nin altında saptanan hastalar vaka grubuna dahil edilmiştir. Ardından, her bir merkezde vaka grubundaki hastalara yaş ve cinsiyet açısından eşleştirilmiş, hipoglisemi atağı bulunmayan Tip 2 DM hastaları kontrol grubu olarak kabul edilmiştir. Ayrıca, Hipoglisemi Korku Ölçeği (HKÖ) iki merkezdeki vaka grubuna da uygulanmıştır. Bulgular: Çalışmaya dahil edilen 240 hastanın 150 (%62,5)’si kadın idi. HYDM’deki tüm hastaların 53(%1,2)’ünde hipoglisemi saptanmışken, AHYDM’den katılan tüm hastaların 27(%0,31)’sinde hipoglisemi tespit edilmiştir. Her iki merkezdeki vaka grubunda DM süresi, insülin kullanım sıklığı ve toplam insülin dozu kontrol grubundan yüksekti (sırasıyla, HYDM için p=0,049, p<0,001, p=0,001; AHYDM için p=0,014, p0,05). Sonuç: DM hastalarında, özellikle insülin kullanan ve T2DM süresi uzun olan hastalarda hipoglisemi açısından dikkatli değerlendirilmesi gereklidir. Ayrıca hastaların aile hekimleri tarafından hipoglisemi ile ilgili eğitilmesi hipoglisemi görülme sıklığını azaltabilir.


  • Difficulties Related to Sarcopenic Obesity

    by Sabah Tüzün

    Sayın Editör, Obezite ile sarkopeninin birlikteliği olarak tanımlanan sarkopenik obezite (SO) tüm dünyada yaşlı nüfustaki artışa bağlı olarak giderek önem